• 1
    Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37: S4S66.
  • 2
    Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. Version 1.0. IARC CancerBase No. 5. Lyon: IARC Press, 2001.
  • 3
    Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003; 39: 171829.
  • 4
    Quinn M, Allen E. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. BMJ 1995; 311: 13915.
  • 5
    Hermon C, Beral V. Breast cancer mortality rates are leveling off or beginning to decline in many western countries: analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries. Br J Cancer 1996; 73: 95560.
  • 6
    Robertson C, Perone C, Primic-Zakelj M, Pompe Kirn V, Boyle P. Breast cancer incidence rates in Slovenia 1971-1993. Int J Epidemiol 2000; 29: 96974.
  • 7
    Tyczynski JE. A plateau of breast cancer mortality in Poland—an impact of time periods or birth generations? A joinpoint regression and APC analysis of recent time trends. Nowotwory J Oncol 2003; 4: 398404.
  • 8
    Doll R, Cook P. Summarizing indices for comparison of cancer incidence data. Int J Cancer 1967; 2: 26979.
  • 9
    Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 33551.
  • 10
    National Cancer Institute. Joinpoint regression program. Version March 2002.
  • 11
    WHO-EURO. Health for all database. Copenhagen: WHO Euro, 2003.
  • 12
    Berrino F, Capocaccia R, Esteve J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A. Survival of cancer patients in Europe: the EUROCARE-2 study. no. 151. Lyon: IARC, 1999.
  • 13
    Lacey JV, Devesa SS, Brinton LA. Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 2002; 39: 828.
  • 14
    Shapiro S, Coleman EA, Broeders M, Codd M, Koning H de, Fracheboud J, Moss S, Paci E, Stachenko S, Ballard-Barbash R. Breast cancer screening programs in 22 countries: current policies, administration and guidelines. Int J Epidemiol 1998; 27: 73542.
  • 15
    Ballard-Barbash R, Klabunde C, Paci E, Broeders M, Coleman EA, Fracheboud J, Bouchard F, Rennert G, Shapiro S. Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment. Eur J Cancer Prev 1999; 8: 41726.
  • 16
    Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol 2003; 4: 2514.
  • 17
    Paci E, Giorgi D, Bianchi S, Vezzosi V, Zappa M, Crocetti E, Rosselli del Turco M. Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures. Eur J Cancer 2002; 38: 56873.
  • 18
    Otto SJ, Fracheboud J, Looman CWN, Broeders MJM, Boer R, Hendriks JHCL, Verbeek ALM, Koning HJ de. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003; 361: 14117.
  • 19
    Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–1998: comparison of observed with predicted mortality. BMJ 2000; 321: 6659.
  • 20
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 115, 71–85.
  • 21
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998; 351: 145167.
  • 22
    Plesko I, Obsitníkova A, Cuninkova M. Epidemiological aspects of in situ female breast cancer in Slovakia. Klinicka onkologie 2003; 16: 22730.
  • 23
    McPherson K, Steel CM, Dixon JM. Breast cancer—epidemiology, risk factors, and genetics. BMJ 2000; 321: 6248.
  • 24
    Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001; 2: 13340.
  • 25
    Vatten LJ, Kvinnsland S. Pregnancy-related factors and risk of breast cancer in a prospective study of 29,981 Norwegian women. Eur J Cancer 1992; 28A: 114853.
  • 26
    Clavel-Chapelon F, E3N-EPIC Group. Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer 2002; 86: 7237.
  • 27
    Staszewski J. Age at menarche and breast cancer. J Natl Cancer Inst 1971; 47: 93540.
  • 28
    Plesko I, Preston-Martin S, Day NE, Tzonou A, Dimitrova E, Somogyi J. Parity and cancer risk in Slovakia. Int J Cancer 1985; 36: 52933.
  • 29
    East-European Study Group of Breast Cancer Epidemiology (EESGBCE). Comparative study of breast cancer risk factors in Estonia and Slovakia. Neoplasma 1990; 37: 97104.
  • 30
    Primic-Zakelj M, Evstifeeva T, Ravnihar B, Boyle P. Breast-cancer risk and oral contraceptive use in Slovenian women aged 25 to 54. Int J Cancer 1995; 62: 41420.
  • 31
    Robertson C, Primic-Zakelj M, Boyle P, Hsieh C-C. Effect of parity and age at delivery on breast cancer risk in Slovenian women aged 25-54 years. Int J Cancer 1997; 73: 19.
  • 32
    Furberg H, Newman B, Moorman P, Millikan R. Lactation and breast cancer risk. Int J Epidemiol 1999; 28: 396402.
  • 33
    Collaborative Group on Hormonal Factors in Breast Cancer (CGHFBC). Breast cancer and breast-feeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96,973 women without the disease. Lancet 2002; 360: 18795.
  • 34
    Lipworth L, Bailey LR, Trichopoulos D. History of breast-feeding in relation to breast cancer risk: a review of the epidemiological literature. J Natl Cancer Inst 2000; 92: 30212.
  • 35
    Sant M, Capocaccia R, Coleman MP, Berrino F, Gatta G, Micheli A, Verdecchia A, Faivre J, Hakulinen T, Coebergh JWW, Martinez-Garcia C, Forman D, et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001; 37: 165967.
  • 36
    Quinn MJ, Martinez-Garcia C, Berrino F. Variations in survival from breast cancer in Europe by age and country, 1978-1989. Eur J Cancer 1998; 34: 220411.
  • 37
    Sant M, Aareleid T, Berrino F, Bielska-Lasota M, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda T, Moller H, Verdecchia A, Capocaccia R, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94—results and commentary. Ann Oncol 2003; 14( Suppl): v6118.
  • 38
    Aareleid T, Brenner H. Trends in cancer patients survival in Estonia before and after the transition from a Soviet Republic to an open-market economy. Int J Cancer 2002; 102: 4550.
  • 39
    Sant M, Eurocare Working Group. Differences in stage and therapy for breast cancer across Europe. Int J Cancer 2001; 93: 894901.